Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula.
Laura Dell'ArtiGiulio BarteselliLorenzo RivaElisa CariniGiovanna GraziadeiEleonora BenattiAlessandro InvernizziMaria D CappelliniFrancesco ViolaPublished in: PloS one (2018)
Chronic chelation therapy and, potentially, high levels of HbF are possible protective factors for the presence of sickle cell maculopathy, especially for patients with more advanced forms of sickle cell retinopathy. A subtle thinning of the overall macula occurs in SCD patients and involves multiple retinal layers, suggesting that ischemic vasculopathy may happen in both superficial and deep capillary plexi. Thinning of the outer retinal layers suggests that an ischemic insult of the choriocapillaris may also occur in SCD patients.
Keyphrases
- end stage renal disease
- risk factors
- optical coherence tomography
- newly diagnosed
- ejection fraction
- diabetic retinopathy
- prognostic factors
- peritoneal dialysis
- stem cells
- multiple sclerosis
- bone marrow
- oxidative stress
- patient reported
- blood brain barrier
- smoking cessation
- white matter
- cell therapy
- drug induced
- replacement therapy